Old Wine in New Bottles: Continuous Versus Intermittent Renal Replacement Therapy in the ICU*

    loading  Checking for direct PDF access through Ovid

Excerpt

Since the introduction of continuous renal replacement therapy (CRRT) in the 1970s, many investigators have tried to prove that for the treatment of critically ill patients with acute kidney injury (AKI), continuous renal replacement techniques are superior to intermittent techniques. Several clinical arguments were used to support this hypothesis: the higher blood flow and ultrafiltration rates used during intermittent renal replacement therapy (IRRT) often cause hemodynamic instability, and the intermittent nature of the technique causes fluctuations in fluid balance and milieu interieur, which both may have a negative impact on the outcome of the critically ill. However, in 2007, a Cochrane analysis including 15 randomized controlled trials (RCTs) comparing CRRT with IRRT concluded that CRRT offered no survival benefit over IRRT in patients with AKI (1). In addition, survivors treated with CRRT or IRRT had similar expectations of recovery of renal function. In 2013, Schneider et al (2) performed another systematic review and meta-analysis to investigate whether the modality of renal replacement therapy (RRT) had an impact on renal recovery. Twenty-three studies were included, 16 observational studies and seven RCTs. Primary outcome was dialysis dependence among survivors. An interesting finding in this review was that in the observational studies, patients treated with IRRT had a greater risk of dialysis dependence than patients treated with CRRT (relative risk [RR], 1.99; 95% CI, 1.53–2.59), whereas no such difference was found in the RCTs.
In this issue of Critical Care Medicine, Bonnassieux et al (3) report the results of another retrospective cohort study, using data from a large database derived from 291 French ICUs. Patients treated for AKI from 2010 until 2014 were grouped according to the initial modality of treatment: CRRT or intermittent hemodialysis (IHD). Renal recovery was defined as more than 3 days without RRT before discharge. In this observational study, IHD was associated with a lower likelihood of recovery after hospital discharge, with an odds ratio of 0.91 (95% CI, 0.88–0.92), suggesting that CRRT does offer a small but significant therapeutic benefit in terms of renal recovery.
However, this suggestion can be contested. First, it is a matter of debate whether not needing RRT for more than 3 days before discharge covers renal recovery in the long run. Second, the investigators extracted only the initial RRT modality from the database (IHD or CRRT), and details on blood and dialysate flow rates, dialysis dose, and fluid balance are missing. It is therefore impossible to determine whether the two groups were comparable in terms of these variables. This may be important, since during IHD using low blood and dialysate flow rates (prolonged IRRT [PIRRT] or slow low efficiency dialysis [SLED]), hemodynamic stability has been demonstrated to be as well preserved as during CRRT (4, 5).
In recent years, the use of PIRRT has gained popularity because of its greater efficiency in small solute removal combined with lower costs in comparison with CRRT (6). In addition, PIRRT reduces the need of anticoagulation and the treatment can be performed during the night, allowing the patient to be mobilized for physical therapy as well as for diagnostic and therapeutic procedures during the day (7). Recently, a systematic review and meta-analysis comparing the effect of SLED and CRRT on renal recovery after AKI in the ICU was published (8). Eighteen studies were included, four RCTs and 14 observational studies. Renal recovery was defined as not requiring RRT. Meta-analysis results indicated no significant difference between SLED and CRRT in terms of renal recovery and time to renal recovery in surviving patients.
    loading  Loading Related Articles